Magrolimab, Rituximab and Acalabrutinib for Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Results from the Phase 1 PRISM TrialSven de Vos,Patrick M. Reagan,Manish R. Patel,Nakhle S. Saba,Andrew Mortlock, Virginie Cerec,Veerendra Munugalavadla,Melih Acar,Barrett Nuttall,David Jenkins,Rafael White,Megan Callahan,Alessandra Forcina,Mark Roschewski,Ian W. FlinnBlood(2022)引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要